MedPage Today on MSN
Amikacin eases MAC lung disease in first-line treatment
Randomized trial might expand use from refractory cases ...
By Bhanvi Satija LONDON, May 18 (Reuters) - French drugmaker Sanofi said on Monday a trial showed its rare disease therapy ...
Phase 3b ENCORE data assess inhaled amikacin in MAC lung disease. Read more on efficacy, safety, and patient-reported ...
MedPage Today on MSN
Lung Biopsy Cryoprobe Increases Diagnostic Yield Over Standard Forceps
And randomized trial shows safety is on par ...
The Rare Lung Disease Program’s mission is to provide state of the art collaborative evaluation and treatment for patients with rare lung diseases. This program exists to better understand rare lung ...
In an interview with The American Journal of Managed Care ® (AJMC ®) at the American Thoracic Society International ...
Researchers report progress in looking for signs of lung cancer in the blood.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results